Results 221 to 230 of about 25,252 (242)

Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis

Clinical Infectious Diseases, 2007
Marcio Nucci, Jan J De Waele, Luis L Ostrosky-Zeichner   +2 more
exaly  

Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal Therapy

Clinical Infectious Diseases, 2004
Thomas F Patterson, David W Denning
exaly  

caspofungine

2009
Guillaume Chevrel, Virginie Dessus
openaire   +1 more source

Caspofungin

Reactions Weekly, 2009
openaire   +2 more sources

Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial

Clinical Infectious Diseases, 2019
Bart Jan Kullberg, Luis L Ostrosky-Zeichner, Coleman Rotstein   +2 more
exaly  

Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?

Antimicrobial Agents and Chemotherapy, 2013
Eric Dannaoui
exaly  

The antifungal caspofungin increases fluoroquinolone activity against Staphylococcus aureus biofilms by inhibiting N-acetylglucosamine transferase

Nature Communications, 2016
Annabel Braem, Jef Vleugels, Paul M Tulkens   +2 more
exaly  

Elevated Chitin Content Reduces the Susceptibility of Candida Species to Caspofungin

Antimicrobial Agents and Chemotherapy, 2013
Louise A Walker, Neil A R Gow, Carol Anne Munro   +2 more
exaly  

MSG-01: A Randomized, Double-Blind, Placebo-Controlled Trial of Caspofungin Prophylaxis Followed by Preemptive Therapy for Invasive Candidiasis in High-Risk Adults in the Critical Care Setting

Clinical Infectious Diseases, 2014
Shmuel Shoham, Annette Reboli, Juan Pablo Caeiro   +2 more
exaly  

Caspofungin

MEDICRIT Revista de Medicina Crítica, 2007
openaire   +2 more sources